Cite
MLA Citation
Songfeng Chen et al.. “The efficacy and safety of keverprazan, a novel potassium‐competitive acid blocker, in treating erosive oesophagitis: a phase III, randomised, double‐blind multicentre study.” Alimentary pharmacology & therapeutics, vol. 55, no. 12, 2022, pp. 1524–1533. http://access.bl.uk/ark:/81055/vdc_100158020285.0x000048